The UK Register of HIV Seroconverters: methods and analytical issues
暂无分享,去创建一个
Andrew N. Phillips | Kholoud Porter | Am Johnson | Ray P. Brettle | Rjc Gilson | Andrew J. McMichael | Anton Pozniak | Beral | Dj Jeffries | D. Hawkins | R. Brettle | A. McMichael | A. Phillips | J. Weber | J. Darbyshire | A. Pozniak | B. Evans | K. Porter | P. Mortimer | Jonathan Weber | A. Babiker | D. Goldberg | Ag Babiker | A. Johnson | C. Carne | M. Johnson | S. Wellsteed | Béral | R. Gilson | D. Jeffries | David J. Goldberg | C. A. Carne | David Hawkins | Jh Darbyshire | Barry Evans | Ma Johnson | Philip P. Mortimer | S Wellsteed | Am Johnson
[1] Giovanni Rezza,et al. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion , 1994, BMJ.
[2] R Bellocco,et al. Median time from seroconversion to AIDS in Italian HIV-positive haemophiliacs: different parametric estimates. , 1994, Statistics in medicine.
[3] G. Rutherford,et al. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. , 1989, The New England journal of medicine.
[4] J. Kaldor,et al. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor , 1992, The Lancet.
[5] Estimating the AIDS incubation period from a prevalent cohort. , 1991, American journal of epidemiology.
[6] N. Dubin,et al. CD4% is the best predictor of development of AIDS in a cohort of HIV‐infected homosexual men , 1991, AIDS.
[7] J. Margolick,et al. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection. , 1992, JAMA.
[8] J. Phair,et al. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991. , 1993, American journal of epidemiology.
[9] G. Rutherford,et al. Prevalence, incidence, and progression of human immunodeficiency virus infection in homosexual and bisexual men in hepatitis B vaccine trials, 1978-1988. , 1989, American journal of epidemiology.
[10] James J. Goedert,et al. Effect of age at seroconversion on the natural AIDS incubation distribution , 1994, AIDS.
[11] R. Doll,et al. Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom. , 1989, BMJ.
[12] P. Krijnen,et al. Predictors of rapid progression to AIDS in HIV-1 seroconverters. , 1993, AIDS.
[13] A. Blaxhult,et al. The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. , 1990, AIDS.
[14] A Muñoz,et al. Predictors of the risk of development of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: a report from the Multicenter AIDS Cohort Study. , 1992, American journal of epidemiology.
[15] E. Scheibel,et al. Clinical course of primary HIV infection: consequences for subsequent course of infection. , 1989, BMJ.
[16] C. Sabin,et al. Use of CD4 lymphocyte count to predict long term survival free of AIDS after HIV infection , 1994, BMJ.
[17] Graham F. Medley,et al. The treatment‐free incubation period of AIDS in a cohort of homosexual men , 1993, AIDS.
[18] D. Cooper,et al. Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. , 1994, American journal of epidemiology.
[19] R. Park. European AIDS definition , 1992, The Lancet.
[20] S. Buchbinder,et al. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. , 1994, American journal of epidemiology.
[21] N. Jewell,et al. Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. , 1989, Journal of acquired immune deficiency syndromes.
[22] S. Brodine,et al. CD4 lymphocyte counts within 24 months of human immunodeficiency virus seroconversion. Findings in the US Navy and Marine Corps. The Navy Retroviral Working Group. , 1993, Archives of internal medicine.